Search Results - "Whitehead, M. I."

Refine Results
  1. 1
  2. 2

    Effects of low and high dose oestradiol and dydrogesterone therapy on insulin and lipoprotein metabolism in healthy postmenopausal women by Godsland, I. F., Manassiev, N. A., Felton, C. V., Proudler, A. J., Crook, D., Whitehead, M. I., Stevenson, J. C.

    Published in Clinical endocrinology (Oxford) (01-05-2004)
    “…Summary objective  Menopause diminishes insulin secretion and elimination, increases risk of diabetes and adversely affects lipoprotein metabolism. This study…”
    Get full text
    Journal Article
  3. 3

    Systemic absorption of progesterone from Progest cream in postmenopausal women by Cooper, A, Spencer, C, Whitehead, MI, Ross, D, Barnard, GJR, Collins, WP

    Published in The Lancet (British edition) (25-04-1998)
    “…Cooper et al assessed absorption, metabolism and urinary excretion of progesterone in postmenopausal women using Progest cream. Progest shouldn't be…”
    Get full text
    Journal Article
  4. 4

    Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women by Stevenson, J C, Cust, M P, Gangar, K F, Hillard, T C, Lees, B, Whitehead, M I

    Published in The Lancet (British edition) (04-08-1990)
    “…66 early postmenopausal women were randomised to 28-day cycles of either transdermal hormone replacement therapy--continuous oestradiol 17-beta 0.05 mg daily,…”
    Get more information
    Journal Article
  5. 5

    Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy by Godsland, I F, Gangar, K, Walton, C, Cust, M P, Whitehead, M I, Wynn, V, Stevenson, J C

    Published in Metabolism, clinical and experimental (01-07-1993)
    “…Estrogen/progestin steroid combinations adversely affect glucose tolerance and insulin resistance, but their effects in combined hormone replacement therapy…”
    Get more information
    Journal Article
  6. 6

    The role and use of progestogens by Whitehead, M I, Hillard, T C, Crook, D

    Published in Obstetrics and gynecology (New York. 1953) (01-04-1990)
    “…Certain epidemiologic, histologic, and biochemical data on the effects of estrogens and progestogens on the endometrial, physical, psychological, and lipid…”
    Get more information
    Journal Article
  7. 7

    Effect of postmenopausal oestradiol and dydrogesterone therapy on lipoproteins and insulin sensitivity, secretion and elimination in hysterectomised women by Manassiev, N.A, Godsland, I.F, Crook, D, Proudler, A.J, Whitehead, M.I, Stevenson, J.C

    Published in Maturitas (25-07-2002)
    “…Objectives: To investigate in depth the metabolic effects of oestradiol-17 β both alone and in combination with the progestagen dydrogesterone. Methods:…”
    Get full text
    Journal Article
  8. 8

    Psychological impact of screening for familial ovarian cancer by Wardle, F J, Collins, W, Pernet, A L, Whitehead, M I, Bourne, T H, Campbell, S

    “…Psychological distress following false-positive results could constitute a substantial disadvantage of cancer screening. The purpose of this prospective study…”
    Get more information
    Journal Article
  9. 9

    Randomized, double-blind, dose-ranging study of the endometrial effects of a vaginal progesterone gel in estrogen-treated postmenopausal women by Ross, David, Cooper, Alison J., Pryse-Davies, John, Bergeron, Christine, Collins, William P., Whitehead, Malcolm I.

    “…OBJECTIVE: Our purpose was to assess the endometrial effects of two doses of natural progesterone administered by a bioadhesive vaginal gel in estrogen-treated…”
    Get full text
    Journal Article Conference Proceeding
  10. 10

    Long-term effects of transdermal and oral hormone replacement therapy on postmenopausal bone loss by Hillard, T C, Whitcroft, S J, Marsh, M S, Ellerington, M C, Lees, B, Whitehead, M I, Stevenson, J C

    Published in Osteoporosis international (01-11-1994)
    “…Transdermal hormone replacement therapy (HRT) is now an accepted form of treatment, but the long-term skeletal effects have not been assessed. Sixty-six early…”
    Get full text
    Journal Article
  11. 11

    Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on serum lipids and lipoproteins by Crook, D, Cust, M P, Gangar, K F, Worthington, M, Hillard, T C, Stevenson, J C, Whitehead, M I, Wynn, V

    “…We attempted to ascertain whether transdermal postmenopausal estrogen-progestin therapy has the typical effects of oral therapy on serum lipoprotein risk…”
    Get more information
    Journal Article
  12. 12

    Hormone replacement therapy and the cardiovascular system : nonlipid effects by STEVENSON, J. C, CROOK, D, GODSLAND, I. F, COLLINS, P, WHITEHEAD, M. I

    Published in Drugs (Basel) (1994)
    “…Coronary heart disease (CHD) is the leading cause of death in women, and the risk of this disease rises markedly after loss of ovarian function. Hormone…”
    Get full text
    Conference Proceeding Journal Article
  13. 13

    Intranasal salmon calcitonin for the prevention and treatment of postmenopausal osteoporosis by Ellerington, M C, Hillard, T C, Whitcroft, S I, Marsh, M S, Lees, B, Banks, L M, Whitehead, M I, Stevenson, J C

    Published in Calcified tissue international (01-07-1996)
    “…In a randomized, double-blind, placebo-controlled trial, we have studied the effects of intranasal salmon calcitonin (SCT) on bone mineral density (BMD) and…”
    Get full text
    Journal Article
  14. 14

    Transdermal administration of oestrogen/progestagen hormone replacement therapy by Whitehead, M I, Fraser, D, Schenkel, L, Crook, D, Stevenson, J C

    Published in The Lancet (British edition) (10-02-1990)
    “…The effects of an oestrogen/progestagen transdermal therapeutic system (TTS) were evaluated in sixteen oestrogen-deficient women. The patients applied…”
    Get more information
    Journal Article
  15. 15

    Continuous combined conjugated equine estrogen-progestogen therapy: effects of medroxyprogesterone acetate and norethindrone acetate on bleeding patterns and endometrial histologic diagnosis by Hillard, T C, Siddle, N C, Whitehead, M I, Fraser, D I, Pryse-Davies, J

    “…This study was designed to assess the incidence of amenorrhea with continuous combined therapy by using two different progestogens and to determine whether…”
    Get more information
    Journal Article
  16. 16

    Differential effects of transdermal estradiol and sequential progestogens on impedance to flow within the uterine arteries of postmenopausal women by Hillard, T C, Bourne, T H, Whitehead, M I, Crayford, T B, Collins, W P, Campbell, S

    Published in Fertility and sterility (01-11-1992)
    “…To investigate the relationship between estradiol (E2), progestogen, and impedance to blood flow in the uterine artery. Twelve postmenopausal women treated for…”
    Get more information
    Journal Article
  17. 17

    Novel screening strategies for early ovarian cancer by transabdominal ultrasonography by Campbell, S, Royston, P, Bhan, V, Whitehead, M I, Collins, W P

    “…Data collected during a prospective study to assess the efficacy of detecting early ovarian cancer by transabdominal ultrasonography have been used to refine…”
    Get more information
    Journal Article
  18. 18

    Ultrasound screening for familial ovarian cancer by Bourne, T H, Whitehead, M I, Campbell, S, Royston, P, Bhan, V, Collins, W P

    Published in Gynecologic oncology (01-11-1991)
    “…We have used transvaginal ultrasonography to screen 776 asymptomatic women for familial ovarian cancer. Every woman had at least one first- or second-degree…”
    Get more information
    Journal Article
  19. 19

    Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium by Whitehead, M I, Townsend, P T, Pryse-Davies, J, Ryder, T A, King, R J

    Published in The New England journal of medicine (31-12-1981)
    “…To study the effects of exogenous estrogens on the postmenopausal endometrium, and to determine the time course and minimum dosage of added progestins…”
    Get more information
    Journal Article
  20. 20

    Assessment of the potency of orally administered progestins in women by King, R J, Whitehead, M I

    Published in Fertility and sterility (01-12-1986)
    “…The effects of at least three doses of each of five orally administered progestins on estrogen-primed, postmenopausal endometrial biochemistry and morphologic…”
    Get more information
    Journal Article